Authors/Disclosures
|
Enrique C. Leira, MD, MS, FAAN
(University of Iowa Department of Neurology, Comprehensive Stroke Center)
|
Dr. Leira has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Leira has received research support from NIH-NINDS. |
|
Bryan R. Ludwig, MD
(Premier Health - NeuroInterventional Specialists)
|
Dr. Ludwig has nothing to disclose. |
|
James W. Chen, MD, PhD
(WLAVA/UCLA)
|
No disclosure on file |
|
Samantha J. LoRusso, MD
(Kaiser)
|
Dr. LoRusso has nothing to disclose. |
|
Edip M. Gurol, MD
(Massachusetts General Hospital)
|
The institution of Dr. Gurol has received research support from NIH/NINDS. The institution of Dr. Gurol has received research support from Boston Scientific Corporation. The institution of Dr. Gurol has received research support from AVID (a wholly owned subsidiary of Eli Lilly). The institution of Dr. Gurol has received research support from Pfizer. |
|
James C. Torner, PhD
(University of Iowa)
|
The institution of Dr. Torner has received research support from NIH. |
|
Harold P. Adams, Jr., MD, FAAN
(University of Iowa Hospitals)
|
The institution of Dr. Adams has received research support from NINDS. |